NO20043243L - Legemiddelleveringssystem for vedvarende frigivelse av glipizid - Google Patents
Legemiddelleveringssystem for vedvarende frigivelse av glipizidInfo
- Publication number
- NO20043243L NO20043243L NO20043243A NO20043243A NO20043243L NO 20043243 L NO20043243 L NO 20043243L NO 20043243 A NO20043243 A NO 20043243A NO 20043243 A NO20043243 A NO 20043243A NO 20043243 L NO20043243 L NO 20043243L
- Authority
- NO
- Norway
- Prior art keywords
- glipizide
- delivery system
- drug delivery
- sustained release
- sustained
- Prior art date
Links
- 238000012377 drug delivery Methods 0.000 title 1
- ZJJXGWJIGJFDTL-UHFFFAOYSA-N glipizide Chemical compound C1=NC(C)=CN=C1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCCCC2)C=C1 ZJJXGWJIGJFDTL-UHFFFAOYSA-N 0.000 title 1
- 229960001381 glipizide Drugs 0.000 title 1
- 238000013268 sustained release Methods 0.000 title 1
- 239000012730 sustained-release form Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34526702P | 2002-01-04 | 2002-01-04 | |
| PCT/US2003/000160 WO2003057278A2 (fr) | 2002-01-04 | 2003-01-04 | Systeme d'apport de medicament destine a l'apport continu de glipizide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20043243L true NO20043243L (no) | 2004-08-02 |
Family
ID=23354287
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20043243A NO20043243L (no) | 2002-01-04 | 2004-08-02 | Legemiddelleveringssystem for vedvarende frigivelse av glipizid |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20030224050A1 (fr) |
| EP (1) | EP1575639A2 (fr) |
| JP (1) | JP2005525311A (fr) |
| KR (1) | KR20040081446A (fr) |
| CN (1) | CN101410091A (fr) |
| AU (1) | AU2003202879A1 (fr) |
| CA (1) | CA2471211A1 (fr) |
| MX (1) | MXPA04006522A (fr) |
| NO (1) | NO20043243L (fr) |
| PL (1) | PL377117A1 (fr) |
| RU (1) | RU2004123792A (fr) |
| WO (1) | WO2003057278A2 (fr) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0102342D0 (en) * | 2001-01-30 | 2001-03-14 | Smithkline Beecham Plc | Pharmaceutical formulation |
| PA8578501A1 (es) | 2002-07-25 | 2005-02-04 | Pharmacia Corp | Forma de dosificacion una vez al dia de pramipexol |
| US20050042289A1 (en) * | 2003-04-29 | 2005-02-24 | Yamanouchi Pharma Technologies, Inc. | Tablets and methods for modified release of hydrophylic and other active agents |
| SI21637A (sl) * | 2003-12-23 | 2005-06-30 | LEK farmacevtska dru�ba d.d. | Farmacevtska oblika z nadzorovanim sproščanjem |
| CN101137352A (zh) * | 2005-01-21 | 2008-03-05 | 诺瓦制药公司 | 药物配制剂及其用法 |
| PL204780B1 (pl) * | 2006-06-02 | 2010-02-26 | Zak & Lstrok Ady Farmaceutyczn | Tabletka powlekana o przedłużonym uwalnianiu substancji aktywnej otrzymywana metodą bezpośredniego tabletkowania zawierająca indapamid albo jego farmaceutyczną sól oraz farmaceutycznie dopuszczalne wypełniacze, zastosowanie karbomeru do wytwarzania tabletki oraz sposób jej powlekania |
| KR101152977B1 (ko) * | 2009-12-14 | 2012-06-11 | 근화제약주식회사 | 약제학적 제제 |
| CN103211787B (zh) * | 2012-01-18 | 2017-06-06 | 北京天衡医院管理有限公司 | 格列吡嗪膜控缓释微丸胶囊 |
| US10751287B2 (en) * | 2013-03-15 | 2020-08-25 | Purdue Pharma L.P. | Tamper resistant pharmaceutical formulations |
| CN104666280B (zh) * | 2015-03-21 | 2017-10-13 | 合肥华方医药科技有限公司 | 一种格列吡嗪口腔速溶膜及其制备方法 |
| IT201800011120A1 (it) * | 2018-12-14 | 2020-06-14 | Dpl Pharma S P A | Composizioni farmaceutiche orali solide per la somministrazione di mesalazina o suoi derivati |
| CN116407514B (zh) * | 2023-05-10 | 2025-03-14 | 迪沙药业集团有限公司 | 一种格列吡嗪片剂组合物及制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8302708D0 (en) * | 1983-02-01 | 1983-03-02 | Efamol Ltd | Pharmaceutical and dietary composition |
| US5130242A (en) * | 1988-09-07 | 1992-07-14 | Phycotech, Inc. | Process for the heterotrophic production of microbial products with high concentrations of omega-3 highly unsaturated fatty acids |
| US5945125A (en) * | 1995-02-28 | 1999-08-31 | Temple University | Controlled release tablet |
| US5654005A (en) * | 1995-06-07 | 1997-08-05 | Andrx Pharmaceuticals, Inc. | Controlled release formulation having a preformed passageway |
| US6048547A (en) * | 1996-04-15 | 2000-04-11 | Seth; Pawan | Process for manufacturing solid compositions containing polyethylene oxide and an active ingredient |
| US5885616A (en) * | 1997-08-18 | 1999-03-23 | Impax Pharmaceuticals, Inc. | Sustained release drug delivery system suitable for oral administration |
| EP2332522A3 (fr) * | 1998-03-19 | 2011-12-07 | Bristol-Myers Squibb Company | Système d'apport à libération lente biphasique destiné à des médicaments à solubilité elevée et procédé associé |
-
2003
- 2003-01-04 WO PCT/US2003/000160 patent/WO2003057278A2/fr not_active Ceased
- 2003-01-04 CN CNA038032864A patent/CN101410091A/zh active Pending
- 2003-01-04 PL PL377117A patent/PL377117A1/pl unknown
- 2003-01-04 EP EP03701991A patent/EP1575639A2/fr not_active Withdrawn
- 2003-01-04 JP JP2003557635A patent/JP2005525311A/ja active Pending
- 2003-01-04 CA CA002471211A patent/CA2471211A1/fr not_active Abandoned
- 2003-01-04 RU RU2004123792/15A patent/RU2004123792A/ru not_active Application Discontinuation
- 2003-01-04 US US10/336,243 patent/US20030224050A1/en not_active Abandoned
- 2003-01-04 KR KR10-2004-7010554A patent/KR20040081446A/ko not_active Withdrawn
- 2003-01-04 AU AU2003202879A patent/AU2003202879A1/en not_active Abandoned
- 2003-01-04 MX MXPA04006522A patent/MXPA04006522A/es not_active Application Discontinuation
-
2004
- 2004-08-02 NO NO20043243A patent/NO20043243L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA04006522A (es) | 2004-10-04 |
| EP1575639A2 (fr) | 2005-09-21 |
| RU2004123792A (ru) | 2005-04-10 |
| JP2005525311A (ja) | 2005-08-25 |
| CN101410091A (zh) | 2009-04-15 |
| CA2471211A1 (fr) | 2003-07-17 |
| WO2003057278A3 (fr) | 2013-12-19 |
| AU2003202879A1 (en) | 2003-07-24 |
| WO2003057278A2 (fr) | 2003-07-17 |
| PL377117A1 (pl) | 2006-01-23 |
| KR20040081446A (ko) | 2004-09-21 |
| US20030224050A1 (en) | 2003-12-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1545662T3 (da) | Lægemiddelindgivelsessystem | |
| NO20041315L (no) | Medikamentavleveringssystem | |
| DK1530965T3 (da) | Kontrolleret frigivelsesleveringssystem til nasal applikation | |
| DK1635875T3 (da) | In-situ-geldannende lægemiddeladministrationssystem | |
| EP1807018A4 (fr) | Systeme d'administration in situ de medicaments a liberation controlee | |
| ATE536861T1 (de) | Bioerodierbare arzneimittelabgabesysteme mit verzögerter freisetzung | |
| ATE405630T1 (de) | Wirkstoffabgabesysteme | |
| IL158527A0 (en) | Sustained release drug delivery system containing codrugs | |
| DK1545467T3 (da) | Faste farmaceutiske formuleringer omfattende telmisartan | |
| EP1477403A4 (fr) | Distributeur de medicament | |
| SI1631255T1 (sl) | Sistem za razdeljevanje zdravil | |
| AU2003221770A8 (en) | Controlled release transdermal drug delivery | |
| IL159273A0 (en) | Transdermal delivery system for sustained release of polypeptides | |
| PL376169A1 (en) | Drug delivery system | |
| SK4325U (sk) | Farmaceutická kompozícia s postupným uvoľňovaním | |
| EP1490029A4 (fr) | Systeme d'administration de medicaments a liberation controlee de pravastatine | |
| NO20043243L (no) | Legemiddelleveringssystem for vedvarende frigivelse av glipizid | |
| ATE551051T1 (de) | Orales arzneimittelabgabesystem | |
| EP1503739A4 (fr) | Liberation reguliere de medicaments combines de guaifenesin | |
| ATE327759T1 (de) | Pharmazeutische zusammensetzung mit verlungerter freisetzung | |
| DE60225154D1 (de) | Neues selbstemulgierendes arzneimittelfreisetzungssystem | |
| NO20043576L (no) | Pharmaceutical formulation comprising melatonin | |
| EP1443901A4 (fr) | Systeme de liberation prolongee de medicaments solubles | |
| DE60321572D1 (de) | Transdermales arzneimittelverabreichungssystem | |
| NO20043633L (no) | Oral doseringsform for kontrollert medikamentfrigivning |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |